Federal Register / Vol. 72, No. 15 / Wednesday, January 24, 2007 / Notices 3149 

Reduction Project, Attn: Desk Officer for 

ACF, Fax: 202–395–6974. 

Dated: January 18, 2007. 

Robert Sargis, 

Reports Clearance Officer. 

[FR Doc. 07–272 Filed 1–23–07; 8:45 am] 

BILLING CODE 4184–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Submission for OMB Review; 

Comment Request 

Title: Annual Maintenance-of-Effort 

(MOE) Report. 

OMB No. 0970–0248. 

Description: The Administration for 

Children and Families (ACF) is 

requesting a three-year extension of the 

ACF–204 (Annual MOE Report). The 

report is used to collect descriptive 

program characteristics information on 

the programs operated by States and 

Territories in association with their 

Temporary Assistance for Needy 

Families (TANF) programs. All State 

and Territory expenditures claimed 

toward States’ and Territories’ MOE 

requirements must be appropriate, i.e., 

meet all applicable MOE requirements. 

The Annual MOE Report provides the 

ability to learn about and to monitor the 

nature of State and Territory 

expenditures used to meet State’s and 

Territories’ MOE requirements, and it is 

an important source of information 

about the different ways that States and 

Territories are using their resources to 

help families attain and maintain selfsufficiency. 

In addition, the report is used to 

obtain State and Territory program 

characteristics for ACF’s annual report 

to Congress, and the report serves as a 

useful resource to use in Congressional 

hearings about how TANF programs are 

evolving, in assessing State the Territory 

MOE expenditures, and in assessing the 

need for legislative changes. 

Respondents: The 50 States of the 

United States, the District of Columbia, 

Guam, Puerto Rico, and the Virgin 

Islands. 

ANNUAL BURDEN ESTIMATES

Instrument Number of 

respondents 

Number of 

responses 

per respondent 

Average 

burden hours 

per response 

Total burden 

hours 

ACF–204 .......................................................................................................... 54 1 128 6,912 

Estimated Total Annual Burden Hours: ........................................................................................................................................ 6,912 

OMB Comment: OMB required to 

make a decision concerning the 

collection of information between 30 

and 60 days after publication of this 

document in the Federal Register. 

Therefore, a comment is best assured of 

having its full effect if OMB receives it 

within 30 days of publication. Written 

comments and recommendations for the 

proposed information collection should 

be sent directly to the following: Office 

of Management and Budget, Paperwork 

Reduction Project, Attn: Desk Officer for 

ACF, Fax: 202–395–6974. 

Dated: September 18, 2007. 

Robert Sargis, 

Reports Clearance Officer. 

[FR Doc. 07–273 Filed 1–23–07; 8:45 am] 

BILLING CODE 4184–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. 2007D–0017] 

Guidance for Industry: Certain Human 

Cells, Tissues, and Cellular and 

Tissue-Based Products Recovered 

From Donors Who Were Tested for 

Communicable Diseases Using Pooled 

Specimens or Diagnostic Tests; 

Availability 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing the 

availability of a document entitled 

‘‘Guidance for Industry: Certain Human 

Cells, Tissues, and Cellular and TissueBased Products (HCT/Ps) Recovered 

From Donors Who Were Tested for 

Communicable Diseases Using Pooled 

Specimens or Diagnostic Tests’’ dated 

January 2007. The guidance document 

provides establishments that make HCT/ 

P donor eligibility determinations with 

recommendations concerning the donor 

eligibility requirements contained in 21 

CFR part 1271, subpart C, which became 

effective on May 25, 2005. The guidance 

applies only to certain HCT/Ps that were 

not regulated as HCT/Ps before May 25, 

2005, and that were recovered from 

donors beginning on or after the May 25, 

2005, and within 30 days of the date of 

publication of this document in the 

Federal Register. This guidance has an 

immediate implementation date because 

FDA has determined that prior public 

participation is not feasible or 

appropriate. In certain cases, donor 

retesting needs to be initiated quickly, 

and the availability of certain HCT/Ps 

may be critical to their intended 

recipients. 

DATES: Submit written or electronic 

comments on agency guidances at any 

time. 

ADDRESSES: Submit written requests for 

single copies of the guidance to the 

Office of Communication, Training, and 

Manufacturers Assistance (HFM–40), 

Center for Biologics Evaluation and 

Research (CBER), Food and Drug 

Administration, 1401 Rockville Pike, 

suite 200N, Rockville, MD 20852–1448. 

Send one self-addressed adhesive label 

to assist the office in processing your 

requests. The guidance may also be 

obtained by mail by calling CBER at 1–

800–835–4709 or 301–827–1800. See 

the SUPPLEMENTARY INFORMATION section 

for electronic access to the guidance 

document. 

Submit written comments on the 

guidance to the Division of Dockets 

Management (HFA–305), Food and Drug 

Administration, 5630 Fishers Lane, rm. 

1061, Rockville, MD 20852. Submit 

electronic comments to http:// 

www.fda.gov/dockets/ecomments. 

FOR FURTHER INFORMATION CONTACT: 

Valerie A. Butler, Center for Biologics 

Evaluation and Research (HFM–17), 

Food and Drug Administration, 1401 

Rockville Pike, suite 200N, Rockville, 

MD 20852–1448, 301–827–6210. 

SUPPLEMENTARY INFORMATION: 

I. Background 

FDA is announcing the availability of 

a document entitled ‘‘Guidance for 

Industry: Certain Human Cells, Tissues, 

and Cellular and Tissue-Based Products 

(HCT/Ps) Recovered From Donors Who 


pwalker on PROD1PC71 with NOTICES